Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Virus Research|January 27, 2024
Aged AG129 mice support the generation of highly virulent novel mouse-adapted DENV (1-4) viruses exhibiting neuropathogenesis and high lethalityGazala Siddqui, Preeti Vishwakarma, Shikha Saxena, et al.
Frontiers in Immunology|April 12, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitroPreeti Vishwakarma, Naveen Yadav, Zaigham Abbas Rizvi, et al.
The Journal of Biological Chemistry|July 31, 2020
Identification of an anti-SARS-CoV-2 receptor-binding domain-directed human monoclonal antibody from a naïve semisynthetic libraryHilal Ahmad Parray, Adarsh Kumar Chiranjivi, Shailendra Asthana, et al.
The Journal of Biological Chemistry|August 21, 2020
Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivoSweety Samal, Tripti Shrivastava, Praveen Sonkusre, et al.
Vaccine|May 10, 2026
Comparative immunogenicity of monomeric and tetrameric Nipah virus G glycoprotein-based vaccine candidates demonstrate robust antibody responses in both formsSurbhi Mishra, Varun Kumar, Gurleen Kaur, et al.
Plos One|November 15, 2007
Inhibition of protein aggregation: supramolecular assemblies of arginine hold the keyUtpal Das, Gururao Hariprasad, Abdul S Ethayathulla, et al.
Plos Pathogens|April 7, 2021
Elicitation of potent serum neutralizing antibody responses in rabbits by immunization with an HIV-1 clade C trimeric Env derived from an Indian elite neutralizerRajesh Kumar, Suprit Deshpande, Leigh M Sewall, et al.
International Immunopharmacology|August 24, 2021
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virusPraveenkumar Murugavelu, Reshma Perween, Tripti Shrivastava, et al.
The Lancet. Infectious Diseases|November 28, 2021
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responsesRamachandran Thiruvengadam, Amit Awasthi, Guruprasad Medigeshi, et al.
Plos Pathogens|December 12, 2022
A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concernHilal Ahmad Parray, Naveen Narayanan, Sonal Garg, et al.
Pageof 4